News in brief: Brentuximab PBS-listed for PTCL; Parental PTSD after children’s ALL; Cancer clinical trial participation feedback sought

Brentuximab now PBS-listed for PTCL Australians living with previously untreated CD30 positive peripheral T-cell lymphoma (PTCL) will benefit from an extension of the PBS listing of brentuximab vedotin (Adcetris) from September 1. The listing follows advice from the PBAC meeting in March 2021. Brentixumab was already listed for treatment of other conditions including adults with ...

Already a member?

Login to keep reading.

© 2021 the limbic